Madrigal Pharma Inc Live Stock Price Today, Share Analysis and Chart

Name: Madrigal Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Madrigal Pharmaceuticals Inc
Rating: 1.61933325
Author: Trendlyne DVM scores

Momentum Trap

about

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver f...

501.68 5.80 (1.17%)

89.31% Gain from 52W Low

276.2K

XNAS Volume

XNAS 16 Jan, 2026 4:30 PM (EST)

Low Financial Strength

33.3 / 100

Expensive Valuation

7.5 / 100

Technically Neutral

55.4 / 100

Momentum Trap These stocks have weak financials and expensive valuation. Medium technical scores may weaken. Investors should exercise caution View Similar Embed DVM

613

1Yr Price target upside is 22%

14 analysts

Madrigal Pharma Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Madrigal Pharma Inc Live Stock Price Today, Share Analysis and Chart

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver f...

89.31% Gain from 52W Low

SWOT Analysis

Madrigal Pharma Inc Live Price Chart